Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

32.83
Delayed Data
As of Jul 31
 +0.07 / +0.21%
Today’s Change
19.31
Today|||52-Week Range
34.50
+20.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash144.1M141.7M179.3M280.5M
 
 
 
 
 
Short Term Investment Cash-25.1M-2.2M37.7M101.2M
 
 
 
 
 
Cash & Short Term Investments146.1M141.7M179.3M280.5M
 
 
 
 
 
 
ReceivablesReceivables83.7M96.0M66.2M60.2M
 
 
 
 
 
 
InventoriesInventories14.7M15.2M14.6M65.7M
 
 
 
 
 
 
Current AssetsOther Current Assets10.0M10.5M12.9M25.8M
 
 
 
 
 
Current Assets254.4M263.3M273.1M432.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross241.4M284.7M321.6M393.4M
 
 
 
 
 
Depreciation-32.5M-42.9M-57.4M-79.4M
 
 
 
 
 
Intangible Assets56.9M47.3M85.9M178.1M
 
 
 
 
 
Other Assets69.5M48.0M89.3M186.3M
 
 
 
 
 
Total Assets546.9M564.2M626.6M945.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable40.5M31.3M27.5M40.9M
 
 
 
 
 
Short Term Debt5.4M4.5M0.000.00
 
 
 
Accrued Expenses1.2M1.5M1.3M6.3M
 
 
 
 
 
Other Current Liabilities4.3M3.3M4.4M20.4M
 
 
 
 
 
Other Liabilities71.1M61.9M56.7M92.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt54.1M58.3M62.0M251.0M
 
 
 
 
 
Deferred Taxes-14.0M-11.1M0.00-12.8M
 
 
 
 
Other Liabilities2.0M1.9M3.5M1.2M
 
 
 
 
 
Total Liabilities130.1M122.1M137.5M392.1M
 
 
 
 
 
 
EquityMinority Interest-6.9M-5.4M-876.0K0.00
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity414.2M441.4M489.6M553.2M
 
 
 
 
 
Total Shareholder Equity414.2M441.4M489.6M553.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding36.0M35.9M36.6M37.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.